Features Nationally Scaled RNA Sequencing and Specimen Collection for Multiple Sclerosis and Non-Alcoholic Fatty Liver Disease with Plans to Expand NASHVILLE, Tenn., Oct. 18, 2022 /PRNewswire/ -- ...
NextCODE Health Launches Operations with Exclusive License to Leverage deCODE genetics' Genomics Platform for Sequence-Based Clinical Diagnostics, and $15 Million in Venture Financing CAMBRIDGE, Mass.
Illumina, Inc. and deCODE genetics have announced the formation of a strategic alliance under which the companies plan to co-develop and commercialize DNA-based diagnostic tests in several major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback